Healio Rapid Reviews in Retina™: Emerging Updates from Summer 2025 – Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Key Features

Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits

Topics Covered

This online activity is designed to update clinicians on data presented at the American Society of Retina Specialists 43rd Annual Meeting held in Long Beach, CA, from July 30 to August 2, 2025.
This activity is directed toward retina specialists, comprehensive ophthalmologists, optometrists, and other eye care professionals involved in the treatment of neovascular retinal disease.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Summarize emerging evidence regarding the management of nAMD
• Summarize emerging evidence regarding the management of DME
  
• Identify appropriate patient populations who may benefit from evidence-based therapies used in the management of RVO based on clinical presentation and goals of treatment

Target Audience

This activity is directed toward retina specialists, comprehensive ophthalmologists, optometrists, and other eye care professionals involved in the treatment of neovascular retinal disease.

Additional credit info

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.5 Contact Hour.